MVision AI Segmentation

MVision AI · K212915 · 2022-05-03

MVision AI Segmentation is an AI-enabled medical device from MVision AI, listed by FDA (510(k), K212915) with a decision date of 2022-05-03. Review panel: Radiology.

FDA submission numberK212915
Pathway510(k)
CompanyMVision AI
Review panel (specialty)Radiology
FDA decision date2022-05-03
DecisionSubstantially Equivalent
Product codeQKB
ClassificationRadiological Image Processing Software For Radiation Therapy
Device class2
Regulation number892.2050
Review time (calendar days)232
Applicant countryFI

Official FDA database record · FDA AI-enabled device list

All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.